Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Sell
38
SBSNY Quote, Financials, Valuation and Earnings
Last price:
$29.80
Seasonality move
:
-7.85%
Day range:
$29.80 - $31.10
52-week range:
$24.15 - $42.90
Dividend yield:
0.62%
P/E ratio:
5.82x
P/S ratio:
4.19x
P/B ratio:
2.16x
Volume:
2.1K
Avg. volume:
4.8K
1-year change:
3.49%
Market cap:
$6.9B
Revenue:
$1.5B
EPS (TTM):
$5.12
Analysts' Opinion
-
Consensus RatingSchibsted ASA has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Schibsted ASA has an estimated downside of -- from its current price of $29.80.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $29.80.
Fair Value
-
According to the consensus of 0 analysts, Schibsted ASA has -- downside to fair value with a price target of -- per share.
SBSNY vs. S&P 500
-
Over the past 5 trading days, Schibsted ASA has underperformed the S&P 500 by -12.05% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Schibsted ASA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Schibsted ASA has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Schibsted ASA reported revenues of $242.5M.
Earnings Growth
-
Schibsted ASA earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Schibsted ASA reported earnings per share of $2.03.
Enterprise value:
6.6B
EV / Invested capital:
1.89x
Price / LTM sales:
4.19x
EV / EBIT:
3.42x
EV / Revenue:
4.05x
PEG ratio (5yr expected):
--
EV / Free cash flow:
104.19x
Price / Operating cash flow:
107.84x
Enterprise value / EBITDA:
1.71x
Gross Profit (TTM):
$1.6B
Return On Assets:
25.02%
Net Income Margin (TTM):
72.62%
Return On Equity:
32.35%
Return On Invested Capital:
28.96%
Operating Margin:
16.74%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $1.6B | $1.2B | $1.6B | $224.6M | $242.5M | |
| Gross Profit | $1.6B | $1.2B | $1.6B | $222.4M | $240.7M | |
| Operating Income | $139.5M | $116M | $111.6M | $37.4M | $40.6M | |
| EBITDA | $219.1M | $429.2M | $3.8B | $170.7M | $509.9M | |
| Diluted EPS | -$20.42 | $6.36 | $5.12 | $6.06 | $2.03 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3B | $310.3M | $252.8M | $396.5M | $782.7M | |
| Total Assets | $4.1B | $9.7B | $4.1B | $5.1B | $3.9B | |
| Current Liabilities | $1.6B | $781.1M | $527.6M | $483.1M | $261.9M | |
| Total Liabilities | $2.3B | $1.5B | $1.4B | $1.3B | $733.6M | |
| Total Equity | $1.8B | $8.2B | $2.7B | $3.8B | $3.2B | |
| Total Debt | $407.1M | $730.5M | $687.8M | $548.1M | $287.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $178.1M | $191.3M | $147.6M | $51.6M | $67.5M | |
| Cash From Investing | -$224.2M | $313.7M | $2.6B | -$27.8M | -$13.1M | |
| Cash From Financing | $6.5M | -$401.2M | -$2.2B | -$64.7M | -$286.8M | |
| Free Cash Flow | $72M | $89.1M | $63.2M | $30.5M | $53.9M | |
SBSNY
Sector
Market Cap
$6.9B
--
Price % of 52-Week High
69.46%
--
Dividend Yield
0.62%
--
Shareholder Yield
--
--
1-Year Price Total Return
3.49%
--
Beta (5-Year)
0.705
--
Dividend yield:
0.62%
Annualized payout:
$0.19
Payout ratio:
160.08%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$32.79
200-day SMA
Sell
Level
$30.96
Bollinger Bands (100)
Sell
Level
29.66 - 33.76
Chaikin Money Flow
Sell
Level
-7.4K
20-day SMA
Sell
Level
$33.22
Relative Strength Index (RSI14)
Sell
Level
36.67
ADX Line
Sell
Level
19.93
Williams %R
Buy
Level
-100
50-day SMA
Sell
Level
$33.11
MACD (12, 26)
Sell
Level
-0.30
25-day Aroon Oscillator
Sell
Level
-16
On Balance Volume
Neutral
Level
109K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.9104)
Buy
CA Score
(Annual)
Level (2.1003)
Sell
Beneish M-Score
(Annual)
Level (-0.9163)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-5.8557)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Schibsted ASA is a Norway-based multimedia group that owns and operates newspapers, online classified advertisement websites, publishing houses, and other multimedia services. The company's largest sources of revenue are its Norwegian and Swedish newspapers and tabloid magazines such as Verdens Gang, Aftenposten, and Aftonbladet. It also operates other regional magazines, classified websites, and local newspapers in over 25 different countries around Europe, Asia, Latin America, and Africa. Schibsted's largest newspaper operations outside of Scandinavia are based in Spain and France.
Stock Forecast FAQ
In the current month, SBSNY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SBSNY average analyst price target in the past 3 months is --.
-
Where Will Schibsted ASA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Schibsted ASA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Schibsted ASA?
Analysts are divided on their view about Schibsted ASA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Schibsted ASA is a Sell and believe this share price will rise from its current level to --.
-
What Is Schibsted ASA's Price Target?
The price target for Schibsted ASA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SBSNY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Schibsted ASA is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SBSNY?
You can purchase shares of Schibsted ASA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Schibsted ASA shares.
-
What Is The Schibsted ASA Share Price Today?
Schibsted ASA was last trading at $29.80 per share. This represents the most recent stock quote for Schibsted ASA. Yesterday, Schibsted ASA closed at $29.80 per share.
-
How To Buy Schibsted ASA Stock Online?
In order to purchase Schibsted ASA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is down 8.7% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is up 9.77% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is up 7.96% over the past day.
